Actavis UK has been accused of overcharging the NHS for a lifesaving drug by raising the price by more than 12,000%.
The Competition and Markets Authority (CMA) has accused Actavis UK of breaking competition law by raising the price for 10mg hydrocortisone tablets from 70p to ?88 over eight years.
Hydrocortisone treats life-threatening conditions such as Addison's disease.
Actavis UK's current owner, Teva, said it would defend the allegations.
Between 2008 and 2015, the CMA claims that the NHS's spending on the drug rose from ?522,000 to ?70m.
That's what private companies do, they see the NHS as a profit making enterprise and milk it for all they can get. That example really is taking the pi$$. Bet they get away with it as well, rather than paying back the 100's of millions they took out of the NHS while profiting on illness.
The Competition and Markets Authority (CMA) has accused Actavis UK of breaking competition law by raising the price for 10mg hydrocortisone tablets from 70p to ?88 over eight years.
Hydrocortisone treats life-threatening conditions such as Addison's disease.
Actavis UK's current owner, Teva, said it would defend the allegations.
Between 2008 and 2015, the CMA claims that the NHS's spending on the drug rose from ?522,000 to ?70m.
That's what private companies do, they see the NHS as a profit making enterprise and milk it for all they can get. That example really is taking the pi$$. Bet they get away with it as well, rather than paying back the 100's of millions they took out of the NHS while profiting on illness.

Comment